Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04544046 · ClinicalTrials.gov registry record · NA

Supportive Oncology Care At Home RCT

A NA study of Lymphoma and Pancreatic Cancer, sponsored by Massachusetts General Hospital.

Active
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT04544046 is a NA study of Lymphoma and Pancreatic Cancer that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 300 participants, below the 483-participant average among 299 other Lymphoma trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04544046, a NA study of Lymphoma and Pancreatic Cancer, is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

This research study is evaluating a program that entails remote monitoring and home-based care for people with cancer who are receiving chemotherapy, radiotherapy, or chemoradiotherapy.

Interventions

  • OTHER Usual Care
  • OTHER Supportive Oncology Care at Home

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2020-09-16
Est. Completion 2025-12-31
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT04544046

The ClinicalTrials.gov registry entry for NCT04544046 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 483-participant average among 299 other Lymphoma trials with a reported enrollment target (38% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Lymphoma appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT04544046 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04544046 about?

NCT04544046 is a clinical study titled "Supportive Oncology Care At Home RCT". This research study is evaluating a program that entails remote monitoring and home-based care for people with cancer who are receiving chemotherapy, radiotherapy, or chemoradiotherapy.

What is the current status of trial NCT04544046?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2020-09-16. Estimated completion is 2025-12-31.

What conditions does trial NCT04544046 study?

This clinical trial studies the following conditions: Lymphoma, Pancreatic Cancer, Head and Neck Cancer, Rectal Cancer, GastroEsophageal Cancer.

What interventions are being tested in trial NCT04544046?

The interventions under investigation include: Usual Care (OTHER), Supportive Oncology Care at Home (OTHER).

Who is sponsoring clinical trial NCT04544046?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04544046 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lymphoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.